Drugs / PH100
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04335045 Comparator | Sep 2013 → Dec 2014 | — | Phloronol Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PH100 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04335045 ↗ |
| Known as | Ecklonia Cava Phlorotannins | “Phase I Study of PH100 (Ecklonia Cava Phlorotannins)” NCT04335045 ↗ |
| Route | Oral | “single, ascending, oral doses of PH100 Capsules” NCT04335045 ↗ |